NCT00816972View on ClinicalTrials.gov

Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)

PHASE2CompletedINTERVENTIONAL

Enrollment

540

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Post-nasal DripSeasonal Allergic RhinitisRhinorrhea

Interventions

DRUG

Desloratadine 2.5 mg

Desloratadine 2.5 mg BID

DRUG

Oxybutynin 2.5 mg

Oxybutynin 2.5 mg BID

DRUG

Placebo for Desloratadine 2.5 mg

Placebo BID

DRUG

Placebo for Oxybutynin 2.5 mg

Placebo BID

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00816972 - Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED) | Biotech Hunter | Biotech Hunter